See more : Winshear Gold Corp. (HELOF) Income Statement Analysis – Financial Results
Complete financial analysis of China Life Insurance Company Limited (LFC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Life Insurance Company Limited, a leading company in the Insurance – Life industry within the Financial Services sector.
- Joyware Electronics Co.,Ltd (300270.SZ) Income Statement Analysis – Financial Results
- Tipco Asphalt Public Company Limited (TASCO-R.BK) Income Statement Analysis – Financial Results
- Shopify Inc. (SHOP.TO) Income Statement Analysis – Financial Results
- Dimension Computer Technology Co., Ltd. (6140.TWO) Income Statement Analysis – Financial Results
- Stadio Holdings Limited (SDO.JO) Income Statement Analysis – Financial Results
China Life Insurance Company Limited (LFC)
About China Life Insurance Company Limited
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/women/pension, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 734.85B | 803.98B | 824.53B | 804.96B | 729.47B | 627.42B | 643.36B | 540.78B | 507.45B | 440.77B | 417.88B | 371.49B | 370.90B | 385.84B | 339.29B | 166.81B | 191.37B | 147.31B | 98.21B | 76.81B | 78.88B | 74.31B | 61.21B |
Cost of Revenue | -94.41B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 829.26B | 803.98B | 824.53B | 804.96B | 729.47B | 627.42B | 643.36B | 540.78B | 507.45B | 440.77B | 417.88B | 371.49B | 370.90B | 385.84B | 339.29B | 166.81B | 191.37B | 147.31B | 98.21B | 76.81B | 78.88B | 74.31B | 61.21B |
Gross Profit Ratio | 112.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 41.08B | 39.87B | 40.81B | 37.69B | 40.28B | 37.49B | 35.95B | 31.85B | 27.46B | 25.43B | 24.81B | 23.28B | 0.00 | 20.29B | 18.72B | 12.11B | 11.80B | 9.34B | 7.24B | 6.59B | 6.86B | 0.00 | 0.00 |
Selling & Marketing | -949.00M | 2.89B | 2.92B | 2.67B | 3.23B | 3.08B | 3.23B | 2.83B | 2.51B | 2.47B | 2.68B | 3.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 40.13B | 39.87B | 40.81B | 37.69B | 40.28B | 37.49B | 35.95B | 31.85B | 27.46B | 25.43B | 24.81B | 23.28B | 21.55B | 20.29B | 18.72B | 12.11B | 11.80B | 9.34B | 7.24B | 6.59B | 6.86B | 0.00 | 5.10B |
Other Expenses | 682.48B | -816.37B | -826.34B | -798.59B | -718.88B | -647.41B | -637.64B | -548.79B | -488.98B | -425.80B | -416.36B | -383.80B | -371.22B | -366.89B | -316.97B | -156.35B | -158.19B | -131.05B | -93.94B | -73.89B | -86.01B | -77.82B | -71.02B |
Operating Expenses | 722.61B | -776.50B | -785.53B | -760.91B | -678.60B | -609.92B | -601.68B | -516.94B | -461.52B | -400.36B | -391.56B | -360.52B | -349.67B | -346.60B | -298.25B | -144.24B | -146.39B | -121.71B | -86.70B | -67.30B | -79.15B | -77.82B | -65.92B |
Cost & Expenses | 722.61B | 779.93B | 774.03B | 750.47B | 669.68B | 613.50B | 601.68B | 516.94B | 461.52B | 400.36B | 388.43B | 360.52B | 350.39B | 344.83B | 297.55B | 144.01B | 145.98B | 121.71B | 86.70B | 67.30B | 79.15B | 1.66B | 7.28B |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.35B | 0.00 | 6.74B | 3.97B | 0.00 | 0.00 |
Interest Expense | 0.00 | 4.86B | 5.60B | 3.75B | 4.26B | 4.12B | 4.60B | 4.77B | 4.32B | 4.73B | 4.03B | 2.58B | 873.00M | 27.26B | 0.00 | 0.00 | 0.00 | 1.00B | 705.00M | 4.32B | 1.00M | 0.00 | 0.00 |
Depreciation & Amortization | 4.76B | 5.29B | 4.88B | 4.75B | 4.38B | 2.45B | 2.18B | 2.04B | 2.04B | 2.12B | 2.03B | 1.95B | 1.91B | 1.80B | 1.56B | 1.35B | 14.53B | 11.17B | 8.71B | 6.92B | 6.31B | 0.00 | 0.00 |
EBITDA | 0.00 | 55.66B | 75.26B | 50.89B | 55.25B | 24.19B | 48.96B | 29.93B | 51.42B | 46.63B | 35.46B | 15.83B | 24.33B | 44.12B | 45.47B | 24.50B | 37.06B | 27.51B | 26.09B | 13.82B | 7.28B | -3.51B | -4.71B |
EBITDA Ratio | 0.00% | 4.08% | 5.37% | 6.11% | 7.57% | 3.21% | 7.46% | 5.59% | 10.21% | 10.65% | 8.44% | 4.11% | 6.24% | 11.05% | 12.72% | 14.40% | 31.31% | 24.96% | 20.59% | 21.32% | 7.68% | -4.72% | -7.69% |
Operating Income | 12.24B | 27.48B | 39.00B | 44.06B | 50.87B | 17.50B | 41.67B | 23.84B | 45.93B | 40.40B | 26.33B | 10.97B | 21.23B | 39.24B | 41.04B | 22.58B | 44.98B | 25.61B | 11.51B | 9.50B | -263.00M | -3.51B | -4.71B |
Operating Income Ratio | 1.67% | 3.42% | 4.73% | 5.47% | 6.97% | 2.79% | 6.48% | 4.41% | 9.05% | 9.17% | 6.30% | 2.95% | 5.72% | 10.17% | 12.10% | 13.53% | 23.51% | 17.38% | 11.72% | 12.37% | -0.33% | -4.72% | -7.69% |
Total Other Income/Expenses | -363.00M | -336.00M | -41.24B | -8.76B | -195.00M | -16.49B | -211.00M | -245.00M | -82.00M | 149.00M | 548.00M | -342.00M | -17.62B | -5.17B | 0.00 | -2.62B | -5.58B | -996.00M | -11.62B | -6.35B | 1.23B | -2.00M | 6.00M |
Income Before Tax | 11.88B | 24.05B | 50.50B | 54.49B | 59.80B | 13.92B | 41.67B | 23.84B | 45.93B | 40.40B | 29.45B | 10.97B | 20.51B | 41.01B | 41.75B | 22.80B | 45.39B | 25.61B | 11.51B | 9.50B | -263.00M | -3.51B | -4.70B |
Income Before Tax Ratio | 1.62% | 2.99% | 6.12% | 6.77% | 8.20% | 2.22% | 6.48% | 4.41% | 9.05% | 9.17% | 7.05% | 2.95% | 5.53% | 10.63% | 12.30% | 13.67% | 23.72% | 17.38% | 11.72% | 12.37% | -0.33% | -4.72% | -7.68% |
Income Tax Expense | -10.76B | -9.47B | -1.92B | 3.10B | 781.00M | 1.99B | 8.92B | 4.26B | 10.74B | 7.89B | 4.44B | -304.00M | 2.02B | 7.20B | 8.71B | 1.39B | 6.33B | 5.55B | 2.15B | 2.28B | 1.18B | 14.00M | 4.00M |
Net Income | 21.11B | 32.08B | 50.77B | 50.26B | 58.29B | 11.40B | 32.25B | 19.13B | 34.70B | 32.21B | 24.77B | 11.06B | 18.33B | 33.63B | 32.88B | 21.28B | 39.06B | 20.05B | 9.37B | 7.17B | -1.43B | -3.52B | -4.71B |
Net Income Ratio | 2.87% | 3.99% | 6.16% | 6.24% | 7.99% | 1.82% | 5.01% | 3.54% | 6.84% | 7.31% | 5.93% | 2.98% | 4.94% | 8.72% | 9.69% | 12.76% | 20.41% | 13.61% | 9.54% | 9.34% | -1.81% | -4.74% | -7.70% |
EPS | 0.75 | 1.14 | 1.80 | 1.78 | 2.05 | 0.40 | 1.13 | 0.66 | 1.22 | 1.14 | 0.88 | 0.39 | 0.65 | 1.19 | 1.16 | 0.68 | 1.38 | 0.75 | 0.35 | 0.10 | -0.07 | -0.18 | -0.09 |
EPS Diluted | 0.75 | 1.14 | 1.80 | 1.78 | 2.05 | 0.40 | 1.13 | 0.66 | 1.22 | 1.14 | 0.88 | 0.39 | 0.65 | 1.19 | 1.16 | 0.68 | 1.38 | 0.75 | 0.35 | 0.10 | -0.07 | -0.18 | -0.09 |
Weighted Avg Shares Out | 28.15B | 28.27B | 28.27B | 28.27B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 26.61B | 26.58B | 70.82B | 20.48B | 19.58B | 52.29B |
Weighted Avg Shares Out (Dil) | 28.27B | 28.27B | 28.27B | 28.27B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 26.61B | 26.58B | 70.82B | 20.48B | 19.58B | 52.29B |
China Life Insurance Company Limited Change of President
LFC vs. BRP: Which Stock Is the Better Value Option?
China Life Insurance: Fundamentals Remain Intact
LFC vs. BRP: Which Stock Should Value Investors Buy Now?
4 Low Price-Book Ratio Stocks
3 US-Listed Chinese Value Stocks to Consider
Benjamin Graham's Formula Nails 26 Top Value Dividend Winners For October
LFC or BRP: Which Is the Better Value Stock Right Now?
Ben Graham's Formula Flags 27 Ideal Dividends Ready To Buy Now
3 Top Chinese Stocks to Buy as Regulators Crack Down
Source: https://incomestatements.info
Category: Stock Reports